<DOC>
	<DOCNO>NCT00006518</DOCNO>
	<brief_summary>BACKGROUND : A number important scientific advance make study blood , bone marrow , tumor , tissue sample patient HIV infection , infection Kaposi sarcoma associate herpesvirus ( KSHV ) , infection oncogenic virus , cancer . This protocol provide mechanism effect variety study . OBJECTIVES : Acquisition serum , circulate cell , bone marrow , tumor normal tissue sample patient HIV infection , KSHV infection , cancer . ELIGIBILITY : Eligibility criterion include age 18 year old l one following : Exposure risk HIV , KSHV , HPV ; HIV seropositive ; KSHV seropositive ; EBV seropositive ; HTLV-1 seropositive ; malignancy , Castleman disease , skin lesion appearance Kaposi sarcoma ; cervical anal intraepithelial lesion . DESIGN : Blood sample may collect initial visit , follow-up visit . Tumor sample may obtain fine needle aspirate , removal pleural peritoneal fluid , skin punch biopsy , excisional biopsy , provide tumor accessible minimal risk patient . Specific risk describe separate consent obtain time biopsy . Samples study HIV AIDS Malignancy Branch , CCR , NCI ; laboratories NCI-Frederick ; collaborate investigator .</brief_summary>
	<brief_title>Specimen Collections From Patients With HIV Infection , KSHV Infection , Viral-Related Pre-malignant Lesions Cancer</brief_title>
	<detailed_description>BACKGROUND : -A number important scientific advance make study blood , bone marrow , tumor , tissue sample patient HIV infection , infection Kaposi sarcoma associate herpesvirus ( KSHV ) , infection oncogenic virus , cancer . This protocol provide mechanism effect variety study . OBJECTIVES : -Acquisition serum , circulate cell , bone marrow , tumor normal tissue sample patient HIV infection , KSHV infection , cancer . ELIGIBILITY : -Eligibility criterion include age 18 year old least one following : Exposure risk HIV , KSHV , HPV ; HIV seropositive ; KSHV seropositive ; EBV seropositive ; HTLV-1 seropositive ; malignancy , Castleman disease , skin lesion appearance Kaposi sarcoma ; cervical anal intraepithelial lesion . DESIGN : - Blood sample may collect initial visit , follow-up visit . - Tumor sample may obtain fine needle aspirate , removal pleural peritoneal fluid , skin punch biopsy , excisional biopsy , provide tumor accessible minimal risk patient . - Specific risk describe separate consent obtain time biopsy . - Samples study HIV AIDS Malignancy Branch , CCR , NCI ; laboratories NCI-Frederick ; collaborate investigator .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<mesh_term>Giant Lymph Node Hyperplasia</mesh_term>
	<mesh_term>Lymphoma , Primary Effusion</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : Age 18 year old . ECOG performance status less equal 3 . At least one following : Exposure risk HIV , KSHV , HPV ; HIV seropositive ; KSHV seropositive ; EBV seropositive ; HTLV1 seropositive ; Malignancy , Castleman 's disease , skin lesion appearance Kaposi 's sarcoma ; Cervical anal intraepithelial lesion ; Clinical condition report hypothesize associate xenotropic murine leukemia virusrelted virus ( XMRV ) Patients require biopsy medical indication include study solely purpose obtain research sample , include blood , pleural fluid , peritoneal fluid , biopsy sample provide biopsy aspiration procedure low risk : procedure include fine needle aspirate , bone marrow aspirate biopsy , excisional biopsy . Such biopsy completely separate protocol evaluation process . EXCLUSION CRITERIA : Inability provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 27, 2017</verification_date>
	<keyword>Tumor</keyword>
	<keyword>Viruses</keyword>
	<keyword>HIV</keyword>
	<keyword>KSHV</keyword>
	<keyword>AIDS</keyword>
</DOC>